The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 11, 2015

Filed:

Sep. 14, 2012
Applicants:

Beverly L. Wolgast, San Diego, CA (US);

Charles A. Gilson, Iii, San Diego, CA (US);

Shelley Aytes, San Diego, CA (US);

Scott A. Estrada, La Jolla, CA (US);

Dipanjan Sengupta, San Diego, CA (US);

Brian Smith, San Diego, CA (US);

Max Rey, Wallisellen, CH;

Ulrich Weigl, Hilzingen, DE;

Heidedore Jlsabeth Rey-papina, Wallisellen, CH;

Inventors:

Beverly L. Wolgast, San Diego, CA (US);

Charles A. Gilson, III, San Diego, CA (US);

Shelley Aytes, San Diego, CA (US);

Scott A. Estrada, La Jolla, CA (US);

Dipanjan Sengupta, San Diego, CA (US);

Brian Smith, San Diego, CA (US);

Max Rey, Wallisellen, CH;

Ulrich Weigl, Hilzingen, DE;

Assignee:

Arena Pharmaceuticals, Inc., San Diego, unknown;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/55 (2006.01); C07D 223/16 (2006.01); C07D 401/02 (2006.01); C07D 403/02 (2006.01); C07C 209/50 (2006.01); C07C 211/29 (2006.01); C07C 213/02 (2006.01); C07C 215/08 (2006.01); C07C 231/02 (2006.01); C07C 17/16 (2006.01); C07C 25/06 (2006.01); C07C 209/74 (2006.01); C07C 211/27 (2006.01);
U.S. Cl.
CPC ...
C07D 223/16 (2013.01); C07C 17/16 (2013.01); C07C 25/06 (2013.01); C07C 209/50 (2013.01); C07C 209/74 (2013.01); C07C 211/27 (2013.01); C07C 211/29 (2013.01); C07C 213/02 (2013.01); C07C 215/08 (2013.01); C07C 231/02 (2013.01);
Abstract

The present invention provides processes and intermediates for the preparation of 3-benzazepines and salts thereof which can be useful as serotonin (5-HT) receptor agonists for the treatment of, for example, central nervous system disorders such as obesity.


Find Patent Forward Citations

Loading…